Oxford University Hospitals Achieves Technology Accreditation

The Nuffield Orthopaedic Centre (NOC) in Oxford has been rated highly for how it uses technology to improve patient care.

Oxford University Hospitals NHS Foundation Trust, which runs the hospital, has reached 'Stage 6' on the EMR Adoption and Maturity (EMRAM) scale, the second highest rating by the international Healthcare Information and Management Systems Society (HIMSS). HIMSS is a non-profit organisation which works around the world promoting the use of technology to improve patient safety, care quality, cost effectiveness, and access to services.

The NOC was recently accredited following a two-day virtual inspection, showing how the Trust is joining up healthcare for patients through ground-breaking digital initiatives.

Examples include an electronic laboratory requesting and sample collection, a fully integrated blood product ordering, tracking and administration process, and the electronic validation of medications at the point of care, ensuring the right dose of the right drug at the right time to the right patient.

All of these initiatives help record patient information and improve communication between staff about patients' treatment.

Staff at the NOC were the first at the Trust to go live with the Cerner Millennium electronic patient record (EPR) platform, which helps clinicians securely access clinical information about their patients and have been leading the way in the Trust on digital systems ever since.

Paul Altmann, Chief Clinical Information Officer at the Trust, said: "We are committed to the use of technology to improve patient care, so we are delighted to be formally recognised as having achieved Stage 6 at the Nuffield Orthopaedic Centre.

"This accolade puts us among an elite group of leading hospitals and medical centres across the world that use electronic systems as a tool to support clinicians in providing high quality patient care."

OUH will build on the success at the NOC and pursue Stage 6 accreditation across other Trust sites, with the intention of aiming for Stage 7 accreditation in the future, initially at the NOC and ultimately across the Trust.

David Walliker, Chief Digital Officer at the Trust, said: "At the heart of the Trust’s strategy both over the last five years and the next five years has been the concept of Digital by Default. What this means is to convert all our care workflows to digital ones, not just digitise the paper-based process in place prior to digital conversion.

"This recognition reflects how our clinical teams are using advanced technologies, data, and analytics on a daily basis to support and help improve the level of care that they give to our patients.

"A huge thank you to all the staff who have made the delivery of this important OUH milestone possible."

As part of the Trust’s Digital by Default approach, clinicians have information easily available when they need it, paper records are removed, and it delivers greater accuracy in recording of diagnoses, co-morbidities, and complications. This is particularly important and beneficial for staff handovers at the end of shifts.

Simon Noel, Chief Nurse Informatics Officer at the Trust, added: "During the course of our journey to become fully digital we continue to strive to enhance the safety and quality of our patients’ care through the use of technology, but also continue to look for ways in which the technology can be used to improve outcomes and the experience of our patients and staff."

Distie Profit, Managing Director of Cerner UK, the provider of the Trust’s EPR Platform, said: "We are thrilled to be partnered with Oxford University Hospitals as they continue to realise the benefits that the digitisation of care can brings to patients, staff, and the broader health system surrounding the trust - now recognised through the HIMSS EMRAM Level 6 accreditation.

"We look forward to working in lock step with the Trust as they advance and fulfil their digital aspirations."

Oxford University Hospitals NHS Foundation Trust (OUH) is one of the largest acute teaching trusts in the UK, with a national and international reputation for the excellence of its services and its role in patient care, teaching and research.

The Trust supports world-leading research programmes in cardiovascular diseases, musculoskeletal disorders, neurological disorders such as Parkinson’s and Alzheimer’s through its designation as one of the UK’s five comprehensive biomedical centres. It works in close partnership with the University of Oxford and is a leading centre for cancer, neurosciences, diabetes, genetics and many other fields. Research themes of particular strength are: cancer, cardiovascular science, diabetes, endocrinology and metabolism, infection and immunology, musculoskeletal science, neuroscience and reproduction and development.

This brings together academic research expertise with clinical teams to translate medical science into better healthcare treatments. Our patients benefit from world-class discovery and innovation supported by the NIHR Oxford Biomedical Research Centre, a partnership between the Trust and the University of Oxford, funded by the National Institute for Health Research.

The Trust employs over 12,000 staff and consists of four hospitals: the Churchill Hospital, John Radcliffe Hospital and Nuffield Orthopaedic Centre in Oxford and the Horton General Hospital in Banbury. On 1 October 2015 the Trust was awarded Foundation status and became Oxford University Hospitals NHS Foundation Trust.

Most Popular Now

Accelerating Data Solutions to Save LIVE…

The consortium of COVID-X announces the launch of the ​1st Open Call ​framed in a ​2-year initiative that will invest ​4 million € to fast-track to market 30+ European data...

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

Model Used to Evaluate Lockdowns was Fla…

In a recent study, researchers from Imperial College London developed a model to assess the effect of different measures used to curb the spread of the coronavirus. However, the model...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

FDA Releases Artificial Intelligence / M…

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...

First NHS Trust and Sectra Achieve Rapid…

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute...

Bayer Transforms Pharma Business through…

At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are...